Newsletter Quarterly Advocacy Newsletter – Q1 2025 Published on March 14, 2025 by Friends of Cancer Research
Newsletter Quarterly Advocacy Newsletter – Q1 2023 Published on March 13, 2023 by Friends of Cancer Research
News In a first, CMS will test paying less for drugs cleared via accelerated approval Published on February 15, 2023
News FDA, NIH: Telehealth Key To Diversifying Trials, But Hurdles Remain Published on January 12, 2023
News Cancer death rates down but racial disparities persist among Black men and women Published on January 12, 2023
News FDA Increasingly Halting Human Trials as Companies Pursue Risky, Cutting-Edge Drugs Published on January 10, 2023
News CDER director calls for simplifying clinical trials to boost diversity Published on January 10, 2023